Recurrent/RefractoryPrimary Central Nervous System Lymphoma (PCNSL)
1 clinical trials · Condition
◉ Watch Recurrent/RefractoryPrimary Central Nervous System Lymphoma (PCNSL)
| Record | Firm | Date |
|---|---|---|
| A Trial to Compare Ibrutinib Versus Lenalidomide in Combination With MRE-chemotherapy for Adult Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL) (NCT04129710) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2020-01-01 |
Track Recurrent/RefractoryPrimary Central Nervous System Lymphoma (PCNSL) automatically
Every clearance here is in the API, with alerts when new ones post.